The most recent questionnaire for sarcoma centers as published by the DKG, the German Cancer Society, now includes the requirement to provide access to hyperthermia as a treatment method. In this questionnaire, the DKG enforces the ESHO guidelines for administration of hyperthermia. The new approach is already in effect and acts as a pilot in the certification process of treatment centers for sarcomas. This step underscores the relevance of hyperthermia as a treatment modality.